玻璃体腔内注射康柏西普联合激光光凝治疗视网膜中央静脉阻塞的临床分析  被引量:2

Clinical Analysis of Intravitreal Injection of Compaqip Combined with Laser Photocoagulation for Central Retinal Vein Occlusion

在线阅读下载全文

作  者:王丽芳[1] 浦利军 黄爱萍[1] 顾晖晖 WANG Li-Jang;PU Li-jun;HUANG Ai-ping;GU Hui-hui(Department of Ophthalmology,Zhangjiagang First People's Hospital,Zhangjiagang,Jiangsu Province,215600 China)

机构地区:[1]张家港市第一人民医院眼科,江苏张家港215600

出  处:《系统医学》2018年第15期24-26,共3页Systems Medicine

摘  要:目的观察玻璃体腔内注射康柏西普联合激光光凝治疗视网膜中央静脉阻塞的临床疗效。方法随机选取该院2015年1月—2017年2月接收的45例视网膜中央静脉阻塞患者为该次实验研究对象,按照是否给予玻璃体腔内注射康柏西普联合激光光凝治疗将所有患者均分为实验组与对照组,对照组25例患者给予单纯激光光凝治疗,实验组20例患者给予玻璃体腔内注射康柏西普联合激光光凝治疗,比较两组患者治疗效果。结果实验组患者治疗6个月后最佳矫正视力(BCVA)、黄斑中心视网膜厚度(CMT)分别为(1.098±0.265)、(236.54±132.51)μm,均明显优于对照组(t=3.845、2.415,P<0.05)。实验组患者治疗6个月后临床治疗总有效率明显高于对照组(90.0%vs 70.0%)(χ~2=5.761,P<0.05)。结论视网膜中央静脉阻塞患者给予玻璃体腔内注射康柏西普联合激光光凝治疗可有效纠正个体视力,改善患者症状。Objective To observe the clinical efficacy of intravitreal injection of Composcide combined with laser photocoagulation for central retinal vein occlusion. Methods 45 patients with central retinal vein occlusion received from the hospital from January 2015 to February 2017 were randomly selected. All patients were treated with intravitreal injection of Composcide combined with laser photocoagulation. They were divided into experimental group and control group. 25 patients in the control group were treated with laser photocoagulation alone. In the experimental group, 20 patients were treated with intravitreal injection of Composcide combined with laser photocoagulation to compare the therapeutic effects of the two groups. Results The best corrected visual acuity (BCVA) and central macular retinal thickness (CMT) of the experimental group were(1.098±0.265) and (236.54±132.51)μm, respectively, which were significantly better than the control group(t=3.845,2.415,P〈0.05). The total effective rate of clinical treatment in the experimental group was significantly higher than that in the control group (90.0% vs 70.0%)(χ^2=5.761, P〈0.05). Conclusion Intravitreal injection of Compaqip combined with laser photocoagulation can effectively correct individual vision and improve patient symptoms.

关 键 词:玻璃体腔内注射 康柏西普 激光光凝 视网膜中央静脉阻塞 

分 类 号:R779.63[医药卫生—眼科]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象